| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |